Search research articles
Contact Us
Filters
Showing results (191-200 of 198) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 198 results.
Stem Cell Research & Therapy
|
April 15, 2021
Hypoxic preconditioning induces epigenetic changes and modifies swine mesenchymal stem cell angiogenesis and senescence in experimental atherosclerotic renal artery stenosis
Busra Isik, Roman Thaler, Busra B Goksu, et al.
Journal of Hypertension
|
September 2, 2022
Renal denervation in the antihypertensive arsenal - knowns and known unknowns
Franz H Messerli, Chirag Bavishi, Jana Brguljan, et al.
BMJ Open Diabetes Research & Care
|
January 8, 2020
Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy
Xiaohui Bian, Tomás P Griffin, Xiangyang Zhu, et al.
Hypertension (Dallas, Tex. : 1979)
|
October 26, 2018
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
Robert M Carey, David A Calhoun, George L Bakris, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 21, 2016
Relationship of Albuminuria and Renal Artery Stent Outcomes: Results From the CORAL Randomized Clinical Trial (Cardiovascular Outcomes With Renal Artery Lesions)
Timothy P Murphy, Christopher J Cooper, Karol M Pencina, et al.
Diabetes
|
April 16, 2021
Diabetic Kidney Disease Alters the Transcriptome and Function of Human Adipose-Derived Mesenchymal Stromal Cells but Maintains Immunomodulatory and Paracrine Activities Important for Renal Repair
LaTonya J Hickson, Alfonso Eirin, Sabena M Conley, et al.
Ebiomedicine
|
September 23, 2019
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
LaTonya J Hickson, Larissa G P Langhi Prata, Shane A Bobart, et al.
Ebiomedicine
|
January 27, 2020
Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446-456
LaTonya J Hickson, Larissa G P Langhi Prata, Shane A Bobart, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 198) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 198 results.
Stem Cell Research & Therapy
|
April 15, 2021
Hypoxic preconditioning induces epigenetic changes and modifies swine mesenchymal stem cell angiogenesis and senescence in experimental atherosclerotic renal artery stenosis
Busra Isik, Roman Thaler, Busra B Goksu, et al.
Journal of Hypertension
|
September 2, 2022
Renal denervation in the antihypertensive arsenal - knowns and known unknowns
Franz H Messerli, Chirag Bavishi, Jana Brguljan, et al.
BMJ Open Diabetes Research & Care
|
January 8, 2020
Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy
Xiaohui Bian, Tomás P Griffin, Xiangyang Zhu, et al.
Hypertension (Dallas, Tex. : 1979)
|
October 26, 2018
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
Robert M Carey, David A Calhoun, George L Bakris, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 21, 2016
Relationship of Albuminuria and Renal Artery Stent Outcomes: Results From the CORAL Randomized Clinical Trial (Cardiovascular Outcomes With Renal Artery Lesions)
Timothy P Murphy, Christopher J Cooper, Karol M Pencina, et al.
Diabetes
|
April 16, 2021
Diabetic Kidney Disease Alters the Transcriptome and Function of Human Adipose-Derived Mesenchymal Stromal Cells but Maintains Immunomodulatory and Paracrine Activities Important for Renal Repair
LaTonya J Hickson, Alfonso Eirin, Sabena M Conley, et al.
Ebiomedicine
|
September 23, 2019
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
LaTonya J Hickson, Larissa G P Langhi Prata, Shane A Bobart, et al.
Ebiomedicine
|
January 27, 2020
Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446-456
LaTonya J Hickson, Larissa G P Langhi Prata, Shane A Bobart, et al.
Page
of 20